Advent Pharma Ltd. (DSE:ADVENT)

Market Cap	1.29B -14.7%
Revenue (ttm)	516.48M +2.1%
Net Income	57.23M -2.1%
EPS	0.62 -1.5%
Shares Out	93.13M
PE Ratio	22.48
Forward PE	n/a
Dividend	0.05 (0.36%)
Ex-Dividend Date	Nov 23, 2025

Volume	119,487
Average Volume	298,543
Open	14.30
Previous Close	14.00
Day's Range	13.90 - 14.30
52-Week Range	11.50 - 17.20
Beta	0.36
RSI	49.12
Earnings Date	Apr 29, 2026

About Advent Pharma

Advent Pharma Ltd., a pharmaceutical company, manufactures, imports, and markets animal health care drugs, nutritional supplements, and feed additives for livestock in Bangladesh. The company offers poultry, aquaculture, and cattle products. It provides its products in powder, bolus, and liquid dosage forms. It offers Yea-Sacc Bolus, Bioplex Dairy Max Bolus, SUPERIOR SYN BIOTECH, Oxi-D Bolus, and TOXOSORB. Advent Pharma Ltd. was incorporated in 2007 and is based in Dhaka, Bangladesh.

• Industry: Pharmaceutical Preparations
• Founded: 2007
• Employees: 317
• Stock Exchange: Dhaka Stock Exchange
• Ticker Symbol: ADVENT

Financial Performance

In fiscal year 2025, Advent Pharma's revenue was 500.49 million, a decrease of -12.45% compared to the previous year's 571.67 million. Earnings were 66.87 million, a decrease of -20.38%.